Executive Medical Director, Clinical Development Lead - Oncology - Lung & Head/Neck Cancers

GSK Switzerland seeks a Senior Executive Medical Director to lead clinical development for oncology assets in lung and head/neck cancers, defining strategy and governance in a hybrid role based in Baar.

This position serves as the primary clinical strategy leader at the asset level, responsible for shaping the scientific narrative and decision-making framework throughout the product lifecycle. The role acts as a strategic partner within the Medicine Development Team, ensuring clinical development is central to investment and governance choices. Candidates with either medical or non-medical backgrounds are encouraged to apply.

Responsibilities

• Establish and maintain the clinical strategy, scientific narrative, and benefit-risk profile for assigned assets.
• Act as the senior clinical authority within the Medicine Development Team core group, partnering closely with development leaders.
• Present governance and investment cases to senior management, converting clinical evidence into actionable strategic advice.
• Represent Clinical Development in interactions with health authorities, advisory boards, steering committees, and alliance partners.
• Utilize AI-driven insights and advanced analytics to guide asset-level strategic choices.
• Mentor and develop clinical staff, supporting succession planning and capability enhancement.
• Ensure an integrated development approach that aligns target selection, regulatory strategy, and commercial readiness.
• Provide final clinical accountability for scientific communications, including publications and congress presentations.
• Contribute to resourcing and talent calibration decisions across the Oncology Clinical Development function.

Requirements

• Hold a medical degree, PharmD, or PhD.
• Possess clinical development experience in oncology within the pharmaceutical sector, or equivalent scientific/clinical expertise.
• Demonstrate experience in asset, portfolio, or enterprise-level governance and investment decisions.
• Have in-depth knowledge of GCP, ICH, FDA, EMA, NICE, and other relevant regulatory standards.
• Show proven ability to lead and influence cross-functional teams in complex matrix structures.
• Understand clinical development processes, oncology therapeutic areas, and drug approval pathways.
• Experience using data, advanced analytics, or emerging technologies to support clinical decisions.

Nice to have

• Medical degree or equivalent clinical doctorate is preferred.
• Prior experience leading or co-leading interactions with health authorities.
• Board certification or substantial clinical experience in oncology, particularly lung and head/neck cancers.
• Strong executive presence and ability to influence at an enterprise level.
• Track record of translating clinical data into strategic decisions across development and lifecycle stages.
• Cross-functional business acumen spanning clinical, regulatory, commercial, and access domains.

What the company offers

• Annual bonus and eligibility for share-based long-term incentive programs.
• Health care and insurance benefits for employees and their families.
• Retirement benefits.
• Paid holidays, vacation, and extended caregiver, parental, and medical leave.

About the company

GSK Switzerland is dedicated to positively impacting the health of 2.5 billion people by the end of the decade. The organization fosters a culture that is ambitious for patients, accountable for impact, and committed to ethical conduct. Core values include transparency, respect, integrity, inclusion, curiosity, and humility, with a clear focus on patient outcomes.

• Ambitious focus on patient health outcomes.
• Accountability for measurable impact.
• Commitment to doing the right thing.
• Values of transparency, respect, and integrity.
• Emphasis on inclusion, curiosity, and humility.
• Clear focus on patients.

How to apply

Documents to submit:

• CV